American Century Companies’s ACELYRIN SLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-91,390
Closed -$226K 2933
2025
Q1
$226K Buy
91,390
+12,522
+16% +$29.8K ﹤0.01% 2734
2024
Q4
$248K Buy
78,868
+46,802
+146% +$227K ﹤0.01% 2738
2024
Q3
$158K Buy
+32,066
New +$166K ﹤0.01% 2789

Other funds holding SLRN

American Century Companies's SLRN Position: Q2 2025 in Review

American Century Companies sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 91,390 shares — an estimated $226K sold.

American Century Companies first reported a position in SLRN in Q3 2024 and held it in 3 quarters. The position peaked at $248K in Q4 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • American Century Companies reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • American Century Companies sold 91,390 ACELYRIN shares in Q2 2025, an estimated $226K.
  • American Century Companies first reported a position in ACELYRIN in Q3 2024 and held it in 3 quarters.
  • American Century Companies's ACELYRIN position peaked at $248K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on American Century Companies's 13F filing for Q2 2025, filed 12 Aug 2025.